GLTO Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 jun 2024 @ 21:53):
Our systems believe the stock currently is undervalued by 0.08% compare to its pairs and should correct upwards.

Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases...

Stats
Dagens volum	32 658
Gjennomsnittsvolum	161 524
Markedsverdi	13.29M
EPS	$-0.200 ( Q1 \| 2024-04-29 )
Neste inntjeningsdato	( $-0.320 ) 2024-07-29
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.430 (Sector) 42.63 (Industry) 24.32
ATR14	$0.00400 (0.82%)

AADI -5.88%

ABCL 1.28%

ABCM 0.04%

ABEO -3.08%

ABIO -0.30%

ABOS 1.64%

ABSI 3.40%

ABUS -1.15%

ABVX -3.00%

ACAD -0.45%

ACER -17.95%

ACET -9.18%

ACGN 1.29%

ACHL -1.70%

ACHV 2.59%

ACIU -0.50%

ACLX -0.56%

ACRV -4.29%

ACST -3.58%

ACXP 3.69%

ADAG 7.14%

ADAP -3.98%

ADGI 0.87%

ADIL -2.66%

ADMA -1.23%

ADPT 0.44%

ADTX -3.47%

ADVM 1.16%

ADXN -1.60%

AEON -4.67%

AEZS -2.49%

AFMD -3.15%

AGEN -3.83%

AGIO -2.55%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA 8.20%

AKRO -2.26%

AKTX -5.23%

AKUS 0.00%

ALBO 0.00%

ALDX -1.95%

ALEC -0.80%

ALGS -0.37%

ALKS 1.88%

ALLK -11.44%

ALLO -2.50%

ALLR -3.70%

ALNA 3.16%

ALNY 2.14%

ALPN 0.02%

ALPX 0.00%

ALRN -2.18%

ALT -15.31%

ALVR -0.55%

ALXN 0.00%

ALXO -10.59%

ALZN 5.10%

AMRN -4.57%

AMTI -3.13%

ANAB 1.45%

ANEB 7.95%

ANGN 0.00%

ANIX -3.25%

ANL -0.14%

ANNX 3.82%

ANPC -3.15%

APGE 2.00%

APGN 8.48%

APGNW 30.65%

APLM -3.25%

APLS 0.09%

APLT 1.35%

APM 1.47%

APOP 0.38%

APRE -3.13%

APTO 0.62%

APTX 3.17%

APVO 3.21%

ARAV -13.39%

ARCT -6.81%

ARDS -12.13%

ARDX 2.24%

ARGX -0.78%

ARNA 0.00%

ARPO -0.90%

ARQT -3.64%

ARTL -2.50%

ARTLW 0.00%

ARVN 7.22%

ARWR -2.34%

ASLN -2.45%

ASMB -5.55%

ASND -2.24%

ATAI -3.35%

ATHA 7.76%

ATHE 0.08%

ATHX -33.50%

ATNF 2.18%

ATOS 4.83%

ATRA -6.30%

ATXI 1.09%

ATXS -0.45%

AUPH -0.81%

AURA 4.85%

AUTL -3.30%

AVBP -1.68%

AVEO 0.00%

AVIR -1.75%

AVRO -1.41%

AVTE -0.35%

AVTX -4.26%

AVXL -5.80%

AXLA 0.00%

AXSM -1.35%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 1.20%

BCAB -7.17%

BCDA -0.85%

BCDAW -46.41%

BCEL 0.00%

BCLI 3.09%

BCRX 1.73%

BCTX 13.26%

BCTXW 1.97%

BCYC 1.10%

BDRX -5.56%

BDTX 0.21%

BEAM 2.47%

BFRA -2.91%

BGNE -2.89%

BIOR -3.83%

BIVI 1.70%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.89%

BLTE -1.25%

BLU 0.03%

BLUE -4.45%

BMEA -15.27%

BMRN 0.07%

BNOX 4.46%

BNTC -2.95%

BNTX -2.12%

BOLD -11.17%

BOLT 0.33%

BPMC -2.40%

BPTH -4.05%

BPTS -13.47%

BRNS -0.37%

BRTX -5.90%

BTAI 13.53%

BTTX 20.00%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 2.78%

CABA 0.83%

CADL 1.42%

CALA 0.00%

CALC -3.82%

CALT -1.59%

CAPR -0.43%

CARA -11.72%

CARM 6.53%

CASI -1.18%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS 1.45%

CCCC -1.59%

CCXI 0.00%

CDAK 0.00%

CDIO -4.66%

CDIOW 24.00%

CDMO -1.41%

CDMOP 0.04%

CDT -5.69%

CDTTW -39.60%

CDTX -6.36%

CDXC 9.63%

CDXS 9.66%

CELC -3.46%

CELU 0.74%

CELUW 11.80%

CERC -1.68%

CERE -1.75%

CERO -5.02%

CEROW -10.18%

CFRX -27.95%

CGEM 0.12%

CGEN -3.59%

CGON -2.96%

CGTX -3.41%

CHMA -6.00%

CHRS 4.75%

CINC 0.00%

CING -3.90%

CINGW 34.95%

CKPT -0.96%

CLBS -16.75%

CLDX -0.73%

CLGN -0.50%

CLLS -3.11%

CLNN -2.50%

CLNNW 0.00%

CLRB 6.47%

CLSD -2.40%

CLSN -0.68%

CLVS 0.00%

CMMB -2.94%

CMND 2.24%

CMPI 0.00%

CMPX 0.93%

CMRA 0.00%

CMRAW 33.33%

CMRX -4.43%

CNCE 0.00%

CNSP -34.50%

CNST 0.00%

CNTA 0.67%

CNTB -1.50%

CNTX -7.76%

COCP -1.83%

COEPW 32.45%

COGT -2.64%

CORT 3.39%

COYA -2.44%

CPRX -1.39%

CRBP -1.32%

CRBU -7.93%

CRDF 2.43%

CRGX -2.05%

CRIS -2.64%

CRNX -5.93%

CRSP 0.77%

CRTX 2.63%

CRVO -6.30%

CRVS 0.28%

CSBR -0.19%

CTCX 1.20%

CTIC 0.06%

CTMX -3.72%

CTNM 5.57%

CTXR -4.87%

CUE -3.11%

CVAC -4.94%

CVKD -2.34%

CWBR 2.80%

CYAD -12.96%

CYCC 18.13%

CYCCP 5.28%

CYCN 7.81%

CYT -2.27%

CYTK -3.14%

CYTO 0.00%

DARE 0.86%

DAWN -0.15%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 31.86%

DNLI -1.87%

DNTH -2.20%

DOMH 1.06%

DRMA -2.57%

DRMAW -1.25%

DRNA 0.00%

DRTS 0.46%

DRTSW 0.00%

DRUG -0.10%

DSGN -2.42%

DTIL -0.21%

DYAI 9.68%

EARS -1.77%

EDIT -2.91%

EDSA 4.14%

EFTR 1.50%

EFTRW -51.85%

EIGR -9.21%

ELAB -3.01%

ELDN 7.14%

ELEV -1.24%

ELOX 10.77%

ELTX -3.38%

ELVN -1.49%

ELYM 5.44%

ENGN 0.49%

ENGNW -21.67%

ENLV -1.45%

ENOB 1.79%

ENSC 6.55%

ENTA -0.90%

ENTO -4.97%

ENTX 0.53%

ENVB -0.02%

EPIX -2.68%

EPRX -2.87%

EPZM 0.00%

EQ -1.24%

EQRX -2.09%

EQRXW 0.00%

ERAS 6.25%

ERNA -2.78%

ERYP 1.30%

ESLA 4.30%

ESLAW 16.64%

ETNB -6.23%

ETON 2.44%

ETTX 0.00%

EVAX 0.00%

EVGN 3.46%

EVLO 0.00%

EWTX 0.29%

EXAI -0.42%

EXEL 0.92%

EYEG -0.69%

EYEN 0.00%

EYPT -0.18%

FATE -12.25%

FBIO 0.89%

FBIOP 0.87%

FBLG -10.30%

FBRX -0.04%

FDMT -4.68%

FENC -2.66%

FGEN -10.21%

FHTX 8.59%

FIXX 0.77%

FMTX 0.00%

FNCH 0.00%

FOLD -1.87%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE 0.89%

FULC 2.26%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT 0.00%

GANX -1.54%

GBIO -0.71%

GBT 0.01%

GDTC 2.05%

GERN -1.66%

GHRS -4.27%

GLMD -2.48%

GLPG -1.83%

GLSI 10.66%

GLTO -3.86%

GLUE -2.37%

GLYC -15.09%

GMAB -0.41%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -2.34%

GNLX -3.98%

GNPX -4.41%

GNTA 3.94%

GOSS -7.73%

GOVX -6.75%

GOVXW 10.89%

GPCR -5.61%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -2.16%

GRTX -1.66%

GTHX 2.27%

GUTS 0.12%

GXGXW 41.67%

GYRE -5.95%

HALO -0.86%

HARP 0.09%

HCWB -3.76%

HEPA -3.50%

HGEN -84.62%

HILS 5.66%

HLVX 0.42%

HOOK 1.19%

HOTH -3.78%

HOWL 0.43%

HRMY 3.21%

HRTX 8.36%

HSTO 0.00%

HUMA 1.93%

HUMAW -6.25%

IBRX -5.64%

ICCC -2.10%

ICPT 0.21%

ICU 20.03%

ICUCW 4.86%

ICVX -0.91%

IDRA -23.04%

IDYA -3.24%

IFRX -3.52%

IGMS -2.12%

IKNA -1.49%

IKT -2.08%

IMAB -0.58%

IMCR -3.40%

IMGN 0.02%

IMGO 0.00%

IMMP 5.51%

IMMX -3.88%

IMNM 3.68%

IMNN 1.77%

IMPL -27.27%

IMRA 15.96%

IMRN -0.40%

IMRX -3.50%

IMTX -1.25%

IMTXW 6.00%

IMUX -5.50%

IMV 0.00%

IMVT -4.08%

INAB -1.12%

INBX -3.11%

INCY -2.11%

INDP 6.88%

INFI -52.38%

INKT 0.00%

INM 3.06%

INMB 2.38%

INO 1.95%

INSM -0.95%

INTS -3.73%

INVA 0.77%

INZY 1.14%

IOBT -7.48%

IONS 1.48%

IOVA -3.96%

IPA 1.08%

IPHA 2.54%

IPSC -2.34%

IRON -1.82%

ISEE 0.38%

ITOS 2.74%

ITRM 1.36%

IVA 6.96%

IVVD 0.41%

JAGX 0.26%

JANX -4.94%

JAZZ -0.69%

JNCE 0.00%

JSPR -1.51%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.49%

KALV -2.60%

KDNY 0.22%

KMPH -0.34%

KNSA -2.58%

KNTE -0.38%

KOD -8.88%

KPRX -5.76%

KPTI -8.85%

KRBP -10.00%

KRON 1.61%

KROS -0.33%

KRRO -1.59%

KRTX 0.03%

KRYS 0.96%

KTRA 9.72%

KTTA -0.65%

KTTAW 0.92%

KURA 0.93%

KYMR -3.56%

KYTX -5.43%

KZIA 6.13%

KZR -1.77%

LABP 0.57%

LBPH 0.64%

LBPS 0.00%

LBPSW 14.81%

LEGN 3.03%

LENZ -3.21%

LEXX 0.58%

LEXXW -14.63%

LGND -0.82%

LGNDV 0.00%

LGVN -9.09%

LIAN -8.28%

LIFE 2.70%

LIPO -5.29%

LIXT -9.76%

LIXTW 46.21%

LJPC -0.32%

LMNL 0.12%

LOGC 0.43%

LPCN -4.36%

LPTX -1.10%

LQDA 0.24%

LRMR -0.43%

LSTA -1.68%

LTRN 5.49%

LUMO 0.67%

LVTX -5.10%

LXEO -12.98%

LXRX -0.88%

LYEL -35.94%

LYRA 4.19%

MACK 0.10%

MBIO -11.90%

MBRX -1.43%

MCRB 0.80%

MDGL -1.87%

MDNA -13.16%

MDWD 3.78%

MDXG -1.55%

MEIP 0.70%

MESO -1.48%

MGNX -5.24%

MGTA -7.74%

MGTX -0.12%

MGX -0.54%

MIRM -0.42%

MIRO 0.59%

MIST 1.92%

MITO 0.00%

MLEC -6.54%

MLECW 2.31%

MLND -5.36%

MLTX 0.96%

MLYS -8.46%

MNKD -0.67%

MNMD 2.83%

MNOV 1.41%

MNPR -9.34%

MOLN 0.76%

MOR 0.62%

MORF -2.76%

MREO 0.14%

MRKR -0.43%

MRNA -10.77%

MRNS -6.59%

MRSN -3.57%

MRTX -0.17%

MRUS 0.67%

MRVI 1.45%

MTCR -1.29%

MTEM 7.43%

MTP -18.50%

MURA -4.36%

MYMD 2.17%

NAMS -0.15%

NAMSW 0.64%

NAUT 1.11%

NBRV 0.71%

NBSE -1.56%

NBTX 8.91%

NCNA -0.18%

NERV -0.32%

NEXI 1.50%

NGM -1.28%

NGNE 3.57%

NKGN 10.92%

NKGNW -20.00%

NKTR 1.87%

NKTX -2.69%

NLSP 5.63%

NLSPW 26.67%

NMRA -1.26%

NMTR -42.97%

NOVN -24.84%

NRBO 14.85%

NRIX -1.49%

NRSN 0.78%

NRSNW 0.00%

NRXP -8.92%

NRXPW 18.33%

NRXS -1.20%

NTBL 2.63%

NTEC -12.45%

NTHI 0.00%

NTLA -4.83%

NTRBW -31.07%

NUVL -1.94%

NVAX -5.93%

NVCT -8.39%

NVIV -34.28%

NXTC -6.71%

NYMX -0.05%

OABI 3.04%

OABIW -10.06%

OBIO 0.00%

OBSV 0.00%

OCEA -4.23%

OCGN 7.63%

OCS -1.00%

OCUL 0.76%

OCUP 0.00%

ODT -4.27%

OKYO 1.72%

OLMA -4.68%

OMER -2.57%

OMGA -2.08%

ONCO 6.16%

ONCR -3.08%

ONCS 31.87%

ONCT -2.04%

ONCY 2.90%

ONTX -0.47%

ONVO 1.01%

OPNT 0.00%

OPT -5.15%

ORGS -0.69%

ORIC -3.56%

ORMP 16.55%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -0.28%

OVID 0.70%

OYST 0.00%

PALI -0.48%

PASG 0.00%

PBLA -7.50%

PBM -4.75%

PBYI 4.39%

PCSA 0.95%

PCVX 0.56%

PDSB -4.76%

PEPG 1.31%

PGEN -6.39%

PHAR 1.99%

PHAS 0.00%

PHAT 0.00%

PHIO -3.55%

PHIOW 36.47%

PHVS -6.50%

PHXM -5.20%

PIRS 0.11%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -2.56%

PLUR 10.34%

PMN -5.55%

PMVP -1.19%

PNT 0.16%

PPBT 1.64%

PRAX 4.86%

PRDS 0.93%

PRLD -3.43%

PROG -3.47%

PROK 2.01%

PRQR 1.20%

PRTA -3.66%

PRTC 0.49%

PRTG 1.40%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -12.20%

PSTX -4.26%

PTCT -0.03%

PTE -0.82%

PTGX 0.88%

PTIXW -48.41%

PULM 1.56%

PXMD 4.76%

PYPD 1.71%

PYXS 4.58%

QLGN -5.84%

QNCX 2.23%

QNRX 0.84%

QSI -29.12%

QSIAW -9.44%

QTTB 3.59%

QURE -1.46%

RAIN -1.63%

RANI 4.28%

RAPT -1.79%

RARE 1.91%

RCKT -10.31%

REGN -0.26%

RENB -3.42%

REPL -2.38%

RETA 0.02%

REUN -0.89%

REVB -1.40%

REVBU 3.46%

REVBW 5.00%

RGLS -5.61%

RGNX -6.25%

RIGL -6.24%

RLAY -5.71%

RLMD -0.33%

RLYB -5.37%

RNA 2.45%

RNAC 2.69%

RNAZ -1.92%

RNXT 2.23%

ROIV -2.26%

ROIVW 4.56%

RPHM -2.17%

RPRX -0.80%

RPTX -1.47%

RUBY 2.70%

RVLP -32.05%

RVMD -0.55%

RVMDW -29.90%

RVNC -0.21%

RVPH -0.40%

RVPHW -5.28%

RXDX 0.09%

RXRX -6.13%

RYTM -5.73%

RYZB 0.02%

RZLT 3.10%

SABS -1.37%

SABSW -5.53%

SAGE -0.28%

SANA -2.31%

SAVA -4.17%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 1.29%

SCPH 11.62%

SCPS 0.00%

SEEL -3.18%

SEER 0.00%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -5.26%

SGMT -4.83%

SGTX -2.56%

SIOX 22.63%

SLDB -2.41%

SLGL 5.23%

SLN -8.77%

SLNO 0.98%

SLRX 0.40%

SLS -3.85%

SMMT -3.44%

SNDX 2.41%

SNGX 3.40%

SNPX -2.77%

SONN -1.59%

SPPI -0.49%

SPRB -1.63%

SPRC -3.29%

SPRO 0.38%

SRNE 0.00%

SRPT -0.75%

SRRA 0.00%

SRRK -1.99%

SRZN -2.45%

STAB 0.00%

STOK -7.10%

STRO -1.51%

STSA 0.00%

STTK 7.03%

SURF -0.93%

SVRA -4.34%

SWTX 0.49%

SYBX 0.00%

SYRS -2.07%

TALS -0.73%

TARA -7.62%

TARS -2.13%

TBPH 0.18%

TCBP 5.49%

TCDA 0.00%

TCON -0.70%

TCRR 0.00%

TCRT 4.49%

TCRX -2.58%

TECH -1.20%

TENX -0.32%

TERN -6.76%

TFFP -11.17%

TGTX -7.87%

THRX 0.12%

TIL -1.22%

TLC 0.00%

TLSA -4.65%

TNGX -3.78%

TNXP -10.36%

TNYA -6.13%

TPST 5.10%

TRDA -4.77%

TRVI 1.92%

TRVN 3.15%

TSHA -17.04%

TSVT -4.26%

TTNP -6.05%

TVTX 3.71%

TYRA -7.54%

UBX -2.73%

UNCY -4.00%

URGN 3.82%

UTHR -0.42%

VACC 11.36%

VALN -3.15%

VAXX 118.75%

VBIV -0.79%

VBLT -8.77%

VCEL 1.65%

VCNX 9.30%

VCYT -0.97%

VERA -4.48%

VERU 1.45%

VERV -3.54%

VIGL 0.81%

VINC 2.81%

VIR -1.03%

VIRI -5.66%

VIRX 3.47%

VKTX -0.92%

VLON -13.04%

VNDA -3.10%

VOR -6.07%

VRCA 0.85%

VRDN -3.13%

VRNA -1.66%

VRPX 3.58%

VRTX -0.16%

VSTM 4.76%

VTGN -2.26%

VTVT 1.28%

VTYX -1.88%

VXRT -0.39%

VYGR -0.70%

VYNE -5.80%

VYNT 7.78%

WINT -2.72%

WVE -8.69%

XBIO 1.03%

XBIT 4.17%

XCUR 0.23%

XENE -0.92%

XERS 4.76%

XFOR 5.73%

XLO 3.06%

XLRN 0.00%

XNCR 0.26%

XOMA -8.36%

XOMAO -0.45%

XOMAP -0.82%

XRTX -7.96%

YMAB -1.55%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -2.73%

ZNTL -1.07%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-06-20	Prener Anne	Buy	18 000	Stock Option (right to buy)
2024-06-20	Munshi Amit	Buy	18 000	Stock Option (right to buy)
2024-06-20	Goldfischer Carl	Buy	36 000	Stock Option (right to buy)
2024-06-20	Shapiro David	Buy	18 000	Stock Option (right to buy)
2024-06-20	Dallas Jayson Donald Alexander	Buy	18 000	Stock Option (right to buy)

INSIDER POWER
-7.33
Last 97 transactions
Buy: 3 330 854 \| Sell: 1 504 628

Korrelasjon (AI algo v.1.1b): Undervalued: 0.08% $0.490 paired level. (Algoen sporer endringene til de mest korrelerte aksjene i sanntid og gir umiddelbar oppdatering)

Volum Korrelasjon

Lang: -0.02 (neutral)

Kort: -0.58 (weak negative)

Signal:(42.568) Neutral

Galecto, Inc. Korrelasjon

10 Mest positive korrelasjoner
NVNO	0.836

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Galecto, Inc. Korrelasjon - Valuta/Råvare

0.63
( weak )

0.56
( weak )

0.00
( neutral )

0.43
( neutral )

Galecto, Inc. Økonomi

Annual	2023
Omsetning:	$0
Bruttogevinst:	$-830 000 (0.00 %)
EPS:	$-1.440

FY	2023
Omsetning:	$0
Bruttogevinst:	$-830 000 (0.00 %)
EPS:	$-1.440

FY	2022
Omsetning:	$0
Bruttogevinst:	$-490 000 (0.00 %)
EPS:	$-2.44

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-2.05

Financial Reports:

No articles found.

Galecto, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Galecto, Inc.

Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB2064, which is in Phase IIa for the treatment of myelofibrosis. It also develops GB0139, an inhaled inhibitor of galectin-3 that is in Phase IIb clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis, a life-threatening progressive fibrotic disease of the lung; and GB1211, a selective oral galectin-3 inhibitor that is in Phase IIa for the treatment of cancer, as well as in Phase Ib/IIa for fibrosis. Galecto, Inc. was founded in 2011 and is based in Boston, Massachusetts.